← Back to Screener
Certara, Inc. Common Stock (CERT)
Price$6.16
Favorite Metrics
Price vs S&P 500 (26W)-56.68%
Price vs S&P 500 (4W)-11.21%
Market Capitalization$978.71M
All Metrics
P/CF (Annual)10.16x
Book Value / Share (Quarterly)$6.68
P/TBV (Annual)2.28x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)7.67%
Cash Flow / Share (Quarterly)$0.44
Price vs S&P 500 (YTD)-32.84%
Gross Margin (TTM)61.53%
Net Profit Margin (TTM)-0.38%
EPS (TTM)$-0.01
10-Day Avg Trading Volume4.11M
EPS Excl Extra (TTM)$-0.01
Revenue Growth (5Y)11.46%
EPS (Annual)$-0.01
ROI (Annual)-0.12%
Gross Margin (Annual)61.53%
Net Profit Margin (5Y Avg)-3.88%
Cash / Share (Quarterly)$1.19
P/E Basic Excl Extra (TTM)103.67x
Revenue Growth QoQ (YoY)3.28%
ROA (Last FY)-0.10%
Revenue Growth TTM (YoY)8.75%
EBITD / Share (TTM)$0.48
ROE (5Y Avg)-1.30%
Operating Margin (TTM)5.02%
Cash Flow / Share (Annual)$0.44
P/B Ratio0.92x
P/B Ratio (Quarterly)1.32x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)2.58x
Net Interest Coverage (TTM)1.57x
ROA (TTM)-0.10%
EV / EBITDA (TTM)13.95x
EPS Incl Extra (Annual)$-0.01
Current Ratio (Annual)2.05x
Quick Ratio (Quarterly)2.00x
3-Month Avg Trading Volume3.12M
52-Week Price Return-57.29%
EV / Free Cash Flow (Annual)15.51x
P/E Incl Extra (TTM)103.67x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$3.87
P/S Ratio (Annual)2.34x
Asset Turnover (Annual)0.27x
52-Week High$15.38
Operating Margin (5Y Avg)1.50%
EPS Excl Extra (Annual)$-0.01
CapEx CAGR (5Y)27.31%
Tangible BV CAGR (5Y)7.65%
26-Week Price Return-52.69%
Quick Ratio (Annual)2.00x
13-Week Price Return-34.50%
Total Debt / Equity (Annual)0.28x
Current Ratio (Quarterly)2.05x
Enterprise Value$1,082.41
Revenue / Share Growth (5Y)7.39%
Asset Turnover (TTM)0.27x
Book Value / Share Growth (5Y)4.45%
Revenue / Employee (Annual)$0
Pretax Margin (Annual)1.82%
Cash / Share (Annual)$1.19
3-Month Return Std Dev42.88%
Gross Margin (5Y Avg)60.62%
Net Income / Employee (TTM)$-0
EBITDA CAGR (5Y)37.65%
EBITDA Interim CAGR (5Y)0.08%
ROE (Last FY)-0.15%
Net Interest Coverage (Annual)1.57x
EPS Basic Excl Extra (Annual)$-0.01
P/FCF (TTM)14.03x
Receivables Turnover (TTM)4.08x
EV / Free Cash Flow (TTM)15.51x
Total Debt / Equity (Quarterly)0.28x
EPS Incl Extra (TTM)$-0.01
Receivables Turnover (Annual)4.08x
ROI (TTM)-0.12%
P/S Ratio (TTM)2.34x
Pretax Margin (5Y Avg)-2.76%
Revenue / Share (Annual)$2.61
Tangible BV / Share (Annual)$3.87
Forward P/E13.67x
Free OCF CAGR (5Y)13.61%
Price vs S&P 500 (52W)-87.12%
P/E Ratio (TTM)103.67x
Year-to-Date Return-30.19%
5-Day Price Return13.68%
EPS Normalized (Annual)$-0.01
ROA (5Y Avg)-0.87%
Net Profit Margin (Annual)-0.38%
Month-to-Date Return7.89%
Cash Flow / Share (TTM)$0.13
EBITD / Share (Annual)$0.48
Operating Margin (Annual)5.02%
LT Debt / Equity (Annual)0.27x
P/CF (TTM)10.16x
ROI (5Y Avg)-1.01%
P/E Excl Extra (TTM)103.67x
LT Debt / Equity (Quarterly)0.27x
EPS Basic Excl Extra (TTM)$-0.01
P/TBV (Quarterly)2.28x
P/B Ratio (Annual)1.32x
Pretax Margin (TTM)1.82%
Book Value / Share (Annual)$6.68
Price vs S&P 500 (13W)-35.19%
Beta1.56x
P/FCF (Annual)14.03x
Revenue / Share (TTM)$2.63
ROE (TTM)-0.15%
52-Week Low$5.19
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
3.75
3.85
3.80
3.80
Industry Peers — Software(207)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
CERTCertara, Inc. Common Stock | 2.34x | 8.75% | 61.53% | 5.02% | $6.16 |
MSFTMicrosoft Corp | 10.15x | 16.67% | 68.59% | 46.62% | $420.26 |
ORCLOracle Corp | 8.04x | 14.87% | 67.08% | 30.56% | $178.34 |
PLTRPalantir Technologies Inc. Class A Common Stock | 75.96x | 56.18% | 82.37% | 31.59% | $142.76 |
SAPSAP SE | 4.65x | 7.67% | 73.62% | 26.71% | $177.41 |
CRMSalesforce, Inc. | 4.00x | 9.58% | 77.68% | 19.34% | $181.22 |
SHOPShopify Inc. Class A subordinate voting shares | 14.33x | 30.14% | 48.07% | 12.70% | $126.94 |
INTUIntuit Inc | 5.48x | 17.21% | 80.05% | 27.08% | $387.11 |
CRWDCrowdStrike Holdings, Inc. Class A Common Stock | 22.04x | 21.71% | 74.81% | -6.10% | $418.20 |
ADBEAdobe Inc. | 4.04x | 10.96% | 89.40% | 36.65% | $248.16 |
NOWSERVICENOW, INC. | 7.42x | 20.88% | 77.56% | 13.74% | $96.44 |
About
Certara provides biosimulation and regulatory science software that accelerates drug development and market approval. Its modeling, simulation, and assessment solutions help pharmaceutical clients reduce clinical trial costs and timelines while enabling faster regulatory approval. The company operates globally with significant presence across the Americas, EMEA, and Asia Pacific regions.